Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)

This study is testing a brain-based treatment called neurofeedback to help people with rheumatoid arthritis who experience widespread, difficult-to-treat chronic pain (called nociplastic pain). Neurofeedback trains people to regulate their own brain activity, which may help reduce pain that does not respond well to standard treatments. **You may be eligible if...** - You have been diagnosed with rheumatoid arthritis - You also meet the criteria for chronic widespread pain - Your arthritis is currently stable (low joint swelling and normal inflammation levels) - Your pain is rated 4 or higher out of 10 - You are right-handed - You have normal or corrected hearing and vision - You can understand English **You may NOT be eligible if...** - You have significant neurological conditions (multiple sclerosis, stroke, Parkinson's, Alzheimer's, or traumatic brain injury) - You have a serious psychiatric condition such as psychosis or active suicidal thoughts - You are currently changing pain medications or receiving another pain treatment - You are enrolled in another interventional study Talk to your doctor to see if this trial is right for you.